Kcentra FDA Approval History
Last updated by Judith Stewart, BPharm on June 22, 2020.
FDA Approved: Yes (First approved April 29, 2013)
Brand name: Kcentra
Generic name: prothrombin complex concentrate, human
Company: CSL Behring
Treatment for: Reversal of Vitamin K Antagonist (VKA) Anticoagulation
Development timeline for Kcentra
|Apr 29, 2013||Approval FDA Approves Kcentra for the Urgent Reversal of Anticoagulation in Adults with Major Bleeding|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.